Title : Beyond the PD-L1 horizon: In search for a good biomarker to predict success of immunotherapy in gastric and esophageal adenocarcinoma.

Pub. Date : 2019 Feb 1

PMID : 30419350






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Programmed cell death ligand-1 (PD-L1), which is a validated biomarker in non-small cell lung cancer (NSCLC), is often also used to select patients for CIT in the context of gastroesophageal cancer, although this marker has not been validated for this purpose. cit CD274 molecule Homo sapiens
2 Programmed cell death ligand-1 (PD-L1), which is a validated biomarker in non-small cell lung cancer (NSCLC), is often also used to select patients for CIT in the context of gastroesophageal cancer, although this marker has not been validated for this purpose. cit CD274 molecule Homo sapiens
3 This review discusses the value of PD-L1 in selecting patients for CIT in esophageal and gastric cancer. cit CD274 molecule Homo sapiens